Zobrazeno 1 - 10
of 14
pro vyhledávání: '"M. J. Thomason"'
Autor:
D. T. Wademan, L. Busakwe, T. J. Nicholson, M. van der Zalm, M. Palmer, J. Workman, A. Turkova, A. M. Crook, M. J. Thomason, D. M. Gibb, J. Seeley, A. Hesseling, G. Hoddinott, null on behalf of the SHINE trial team
Publikováno v:
The International Journal of Tuberculosis and Lung Disease
SETTING: We conducted a qualitative exploration into the palatability and acceptability of a novel fixed-dose combination (FDC) anti-tuberculosis drug. This study was nested in the SHINE (Shorter treatment for minimal TB in children) trial, which com
Autor:
Sabita S. Soedamah-Muthu, Mike Mackness, J. H. Fuller, M J Thomason, D. J. Betteridge, H. A. W. Neil, P.N. Durrington, K. Julier, Graham A. Hitman, Helen M. Colhoun
Publikováno v:
Atherosclerosis 167 (2003) 2
Atherosclerosis, 167(2), 243-255
Atherosclerosis, 167(2), 243-255
The effect of statin therapy on subclasses of LDL, VLDL and HDL lipoproteins is unclear. We compared changes in serum lipids, apolipoproteins and nuclear magnetic resonance (NMR) spectroscopy measured lipoprotein subclass concentration and average pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ca39aac9cfc1f7cba27561c5736264c
https://doi.org/10.1016/s0021-9150(02)00428-8
https://doi.org/10.1016/s0021-9150(02)00428-8
Autor:
M J Thomason, Helen M. Colhoun, Graham A. Hitman, Mike Mackness, Cards Investigators, H. A. W. Neil, D. J. Betteridge, P.N. Durrington, Shona Livingstone, J. H. Fuller
Publikováno v:
Diabetic Medicine. 21:901-905
AIM: To describe baseline characteristics of patients in the Collaborative AtoRvastatin Diabetes Study (CARDS), a randomized, placebo-controlled trial of lipid lowering with atorvastatin 10 mg daily for the primary prevention of major cardiovascular
Autor:
C A Seymour, M D Bain, Peter Littlejohns, Joanne Lord, M J Thomason, G M Addison, A H Wilcox, R A Chalmers
Publikováno v:
Scopus-Elsevier
STUDY OBJECTIVE: To estimate the net financial benefit of neonatal screening for phenylketonuria (PKU): by a simple pooling of cost data from the literature; and by a more complex modelling approach. DESIGN: A systematic literature review was conduct
Autor:
Anne Umpleby, A. Skottner, Richard H. Jones, Peter H. Sönksen, M. A. Boroujerdi, Fariba Shojaee-Moradie, M. J. Thomason, Nicola Jackson
Publikováno v:
European Journal of Clinical Investigation. 25:920-928
The effect of infusions of recombinant insulin-like growth factor-I (IGF-I) (34, 103 or 688 pmol kg-1 min-1), insulin (3.4, 10.3 or 68.8 pmol kg-1 min-1) or combined infusions (34 pmol IGF-I + 3.4 pmol kg-1 min-1 insulin or 103 pmol IGF-I + 3.4 pmol
Autor:
Richard H. Jones, Peter H. Sönksen, Anne Umpleby, S B Bowes, A. J. Weissberger, J. M. Kelly, M. J. Thomason, David Russell-Jones
Publikováno v:
Clinical Endocrinology. 38:427-431
OBJECTIVE Growth hormone treatment given to adult growth hormone deficient patients leads to an increase in lean body mass by an unknown mechanism. The aim of this study was to investigate the actions of growth hormone treatment on protein metabolism
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 22(8)
AIMS: To study the effect of age at death, sex, ethnic group, date of death, underlying cause of death and social class on the frequency of reporting diabetes on death certificates in known cases of diabetes. METHODS: Data were extracted from certifi
Autor:
Shona Livingstone, Graham A. Hitman, Helen M. Colhoun, Paul N. Durrington, H. A. W. Neil, M J Thomason, D. J. Betteridge, J. H. Fuller
Publikováno v:
Diabetologia. 48(12)
AIMS/HYPOTHESIS: The aim of this study was to determine the pattern of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin on cardiovascular events in patients with type 2 diabetes and no prior history of cardiova
Autor:
Bain, Joanne Lord, M J Thomason, A H Wilcox, R A Chalmers, C A Seymour, Peter Littlejohns, G M Addison, Cockburn F
Publikováno v:
Health Technology Assessment, Vol 1, Iss 11 (1997)
Scopus-Elsevier
Scopus-Elsevier
OBJECTIVES. To establish a database of literature and other evidence on neonatal screening programmes and technologies for inborn errors of metabolism. To undertake a systematic review of the data as a basis for evaluation of newborn screening for in
Publikováno v:
Chirality. 9(3)
Previous investigations have described the development of nongrowing suspensions of Verticillium lecanii as a microbial model of the mammalian chiral inversion of the 2-arylpropionic acids (2-APAs). Mechanistic studies in mammals have shown that inve